The artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research. The report “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others); By Application; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.
Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-sample
Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.
In this direction, in January 2021, the U.S.-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.
Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-discount-pricing
Polaris Market Research has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, and region:
Artificial Intelligence in Drug Discovery, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Drug optimization and repurposing
- Preclinical testing
- Others
Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue – USD Million, 2016 – 2028)
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
Buy Now @ https://www.polarismarketresearch.com/checkouts/8171
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
Web: www.polarismarketresearch.com